Personal information

Other IDs

Loop profile: 2758559

Biography

Li Qiang, Ph.D., is based at the Beijing Institute of Radiation Medicine (China) specializing in Pathology and Pathophysiology. He was mentored by Researcher Xiao Xiaohe for his master's and Academician Wu Zuze for his doctorate. His primary research interests include the immunopharmacology and toxicology of traditional Chinese medicine, stem cells and regenerative medicine, and inflammatory liver disease. He serves on the editorial boards of Innovation, Traditional Medicine Research, and Future Integrative Medicine, and reviews for the journals iScience and Future Integrative Medicine.

He has participated in several significant projects including one Innovation Team and Talents Cultivation Program of the National Administration of Traditional Chinese Medicine, one Beijing Natural Science Foundation Youth Project, one Basic Strengthening Plan Project (Major Basic Research), and four Student Research Training (SRT) Programs. As the first author (including co-first author), he has published five SCI papers with an impact factor greater than 5 in internationally renowned journals such as EMBO Reports (cited 43 times from February 2022 to May 2024) and Phytotherapy Research (including one paper under review). He has also authored two Chinese Core (CSCD) papers and contributed to one medical monograph. Additionally, he has been granted and has applied for six national patents.

Activities

Collapse all

Works (19)

1,2-Propanediol Attenuates Radiation-Induced HaCaT Cell Injury by Inhibiting Oxidative Stress

Biomedical and Environmental Sciences
2024 | Journal article
DOI: 10.3967/BES2024.189
WOSUID: WOS:001390818700012
Contributors: Liu, Yun; Ren, Boyuan; Liu, Yubin; Li, Qiang; Jin, Jiayan; Wu, Chu-tse; Zhou, Gangqiao; Jin, Jide
Source: check_circle
Web of Science Researcher Profile Sync

Recombinant neorudin and its active metabolite hirudin: the fate <i>in vivo</i> of a novel anticoagulant drug

Frontiers in Pharmacology
2024 | Journal article
DOI: 10.3389/FPHAR.2024.1443475
WOSUID: WOS:001325301400001
Contributors: Li, Qiang; Liu, Yubin; Ren, Boyuan; Jin, Jiayan; Zhang, Lin; Wu, ChuTse; Jin, Jide
Source: check_circle
Web of Science Researcher Profile Sync

Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Recombinant Neorudin, a New Anticoagulant Drug in Patients With Acute Coronary Syndrome

Clinical Pharmacology in Drug Development
2024 | Journal article
DOI: 10.1002/CPDD.1478
WOSUID: WOS:001329537600001
Contributors: Liu, Yu-bin; Liang, Yan; Liu, Hui-chen; Feng, Guang-xun; Zhou, Xing-chen; Zhang, Lin; Zhang, Xiao-long; Li, Qiang; Ren, Bo-yuan; Xia, Xia et al.
Source: check_circle
Web of Science Researcher Profile Sync

Radioprotective Effects of Licochalcone B: DNA Protection, Cytokine Inhibition, and Antioxidant Boost

Future Integrative Medicine
2024-08-30 | Journal article
DOI: 10.14218/FIM.2024.00031
Contributors: Boyuan Ren; Jiayan Jin; Yichen Wang; Xiao Xu; Yun Liu; Hongfan Ding; Qiang Li; Ji-de Jin
Source: check_circle
Crossref

Tryptanthrin suppresses multiple inflammasome activation to regulate NASH progression by targeting ASC protein

Phytomedicine
2024-05-28 | Journal article
DOI: 10.1016/j.phymed.2024.155758
Part of ISSN: 0944-7113
Contributors: Lutong Ren; Huijie Yang; Hongbo Wang; Shuanglin Qin; Xiaoyan Zhan; Hui Li; Ziying Wei; Zhie Fang; Qiang Li; Tingting Liu et al.
Source: Self-asserted source
Qiang Li
grade
Preferred source (of 2)‎

Helenine blocks NLRP3 activation by disrupting the NEK7-NLRP3 interaction and ameliorates inflammatory diseases

Phytomedicine
2024-01 | Journal article
DOI: 10.1016/j.phymed.2023.155159
Part of ISSN: 0944-7113
Contributors: Zhi-E Fang; Yan Wang; Shuyi Bian; Shuanglin Qin; Huanying Zhao; Jincai Wen; Tingting Liu; Lutong Ren; Qiang Li; Wei Shi et al.
Source: Self-asserted source
Qiang Li
grade
Preferred source (of 2)‎

Tricyclic antidepressants induce liver inflammation by targeting NLRP3 inflammasome activation

Cell Communication and Signaling
2023-05-25 | Journal article
DOI: 10.1186/s12964-023-01128-x
Part of ISSN: 1478-811X
Contributors: Wenqing Mu; Guang Xu; Zhilei Wang; Qiang Li; Siqiao Sun; Qin Qin; Zhiyong Li; Wei Shi; Wenzhang Dai; Xiaoyan Zhan et al.
Source: Self-asserted source
Qiang Li
grade
Preferred source (of 2)‎

Glycyrrhiza uralensis polysaccharides ameliorate acute lung injury by inhibiting the activation of multiple inflammasomes

Journal of Functional Foods
2023-01 | Journal article
DOI: 10.1016/j.jff.2022.105386
Part of ISSN: 1756-4646
Contributors: Wen Kan; Qiang Li; Pengyan Li; Lutong Ren; Wenqing Mu; Li Lin; Jincai Wen; Feilin Ge; Manting Hou; Siwen Hui et al.
Source: Self-asserted source
Qiang Li
grade
Preferred source (of 2)‎

The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors

Frontiers in Immunology
2023-01-18 | Journal article
DOI: 10.3389/fimmu.2022.1109938
Part of ISSN: 1664-3224
Contributors: Xiaoyan Zhan; Qiang Li; Guang Xu; Xiaohe Xiao; Zhaofang Bai
Source: Self-asserted source
Qiang Li
grade
Preferred source (of 2)‎

[Schisandrin C improves acetaminophen-induced liver injury in mice by regulating Nrf2 signaling pathway]

China Journal of Chinese Materia Medica
2022 | Journal article
DOI: 10.19540/J.CNKI.CJCMM.20220421.704
WOSUID: MEDLINE:36472037
Contributors: Dai, Wen-Zhang; Bai, Zhao-Fang; He, Ting-Ting; Zhan, Xiao-Yan; Li, Qiang; Zhao, Jing; Xiao, Xiao-He
Source: check_circle
Web of Science Researcher Profile Sync

Discovery of bakuchiol as an AIM2 inflammasome activator and cause of hepatotoxicity

Journal of Ethnopharmacology
2022-11 | Journal article
DOI: 10.1016/j.jep.2022.115593
Part of ISSN: 0378-8741
Contributors: Tingting Liu; Guang Xu; Yurong Li; Wei Shi; Lutong Ren; Zhie Fang; Longxin Liang; Yan Wang; Yuan Gao; Xiaoyan Zhan et al.
Source: Self-asserted source
Qiang Li
grade
Preferred source (of 2)‎

Polysaccharide extract from <scp><i>Isatidis Radix</i></scp> inhibits multiple inflammasomes activation and alleviate gouty arthritis

Phytotherapy Research
2022-08 | Journal article
DOI: 10.1002/ptr.7514
Part of ISSN: 0951-418X
Part of ISSN: 1099-1573
Contributors: Lutong Ren; Qiang Li; Hui Li; Xiaoyan Zhan; Ruichuang Yang; Zhiyong Li; Zhie Fang; Tingting Liu; Ziying Wei; Jia Zhao et al.
Source: Self-asserted source
Qiang Li
grade
Preferred source (of 2)‎

Inhibitory effects and mechanisms of the anti-covid-19 traditional Chinese prescription, Keguan-1, on acute lung injury

Journal of Ethnopharmacology
2022-03 | Journal article
DOI: 10.1016/j.jep.2021.114838
Part of ISSN: 0378-8741
Contributors: Zhaofang Bai; Pengyan Li; Jincai Wen; Yanzhong Han; Yuanyuan Cui; Yongfeng Zhou; Zhuo Shi; Shuaishuai Chen; Qiang Li; Xu Zhao et al.
Source: Self-asserted source
Qiang Li
grade
Preferred source (of 2)‎

Isoxanthohumol, a component of Sophora flavescens, promotes the activation of the NLRP3 inflammasome and induces idiosyncratic hepatotoxicity

Journal of Ethnopharmacology
2022-03 | Journal article
DOI: 10.1016/j.jep.2021.114796
Part of ISSN: 0378-8741
Contributors: Li Lin; Yuanyuan Chen; Qiang Li; Guang Xu; Kaixin Ding; Lutong Ren; Wei Shi; Yan Wang; Zhiyong Li; Wenzhang Dai et al.
Source: Self-asserted source
Qiang Li
grade
Preferred source (of 3)‎

Integration of Transcriptomic and Metabolomic Data to Compare the Hepatotoxicity of Neonatal and Adult Mice Exposed to Aristolochic Acid I

Frontiers in Genetics
2022-03-25 | Journal article
DOI: 10.3389/fgene.2022.840961
Part of ISSN: 1664-8021
Contributors: Zhi-e Fang; Chunyu Wang; Ming Niu; Tingting Liu; Lutong Ren; Qiang Li; Zhiyong Li; Ziying Wei; Li Lin; Wenqing Mu et al.
Source: Self-asserted source
Qiang Li
grade
Preferred source (of 2)‎

Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7‐NLRP3 interaction

EMBO reports
2022-02-03 | Journal article
DOI: 10.15252/embr.202153499
Part of ISSN: 1469-221X
Part of ISSN: 1469-3178
Contributors: Qiang Li; Hui Feng; Hongbo Wang; Yinghao Wang; Wenqing Mou; Guang Xu; Ping Zhang; Ruisheng Li; Wei Shi; Zhilei Wang et al.
Source: Self-asserted source
Qiang Li
grade
Preferred source (of 2)‎

Dihydrotanshinone I Specifically Inhibits NLRP3 Inflammasome Activation and Protects Against Septic Shock In Vivo

Frontiers in Pharmacology
2021-10-14 | Journal article
DOI: 10.3389/fphar.2021.750815
Part of ISSN: 1663-9812
Contributors: Ziying Wei; Xiaoyan Zhan; Kaixin Ding; Guang Xu; Wei Shi; Lutong Ren; Zhie Fang; Tingting Liu; Xiaorong Hou; Jia Zhao et al.
Source: Self-asserted source
Qiang Li
grade
Preferred source (of 2)‎

Germacrone Attenuates Hepatic Stellate Cells Activation and Liver Fibrosis via Regulating Multiple Signaling Pathways

Frontiers in Pharmacology
2021-10-05 | Journal article
DOI: 10.3389/fphar.2021.745561
Part of ISSN: 1663-9812
Contributors: Zhiyong Li; Zhilei Wang; Fang Dong; Wei Shi; Wenzhang Dai; Jing Zhao; Qiang Li; Zhi-e Fang; Lutong Ren; Tingting Liu et al.
Source: Self-asserted source
Qiang Li
grade
Preferred source (of 2)‎

The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis Via Modulating Multiple Signaling Pathways in Mice

Frontiers in Pharmacology
2021-06-03 | Journal article
DOI: 10.3389/fphar.2021.655531
Part of ISSN: 1663-9812
Contributors: Yongqiang Ai; Wei Shi; Xiaobin Zuo; Xiaoming Sun; Yuanyuan Chen; Zhilei Wang; Ruisheng Li; Xueai Song; Wenzhang Dai; Wenqing Mu et al.
Source: Self-asserted source
Qiang Li
grade
Preferred source (of 2)‎

Peer review (51 reviews for 14 publications/grants)

Review activity for Chinese herbal medicines. (1)
Review activity for Chinese medical journal. (1)
Review activity for Future integrative medicine. (3)
Review activity for Infectious Medicine (3)
Review activity for Integrative medicine discovery. (1)
Review activity for iScience. (2)
Review activity for Journal of holistic integrative pharmacy. (2)
Review activity for MedComm. (1)
Review activity for Molecular & cellular biomechanics : (1)
Review activity for Pharmacological research. (2)
Review activity for Pharmacological research. (26)
Review activity for Phytomedicine. (3)
Review activity for Phytomedicine. (2)
Review activity for Traditional medicine research. (3)
How many people are using ORCID?